We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.5B
1-Year Est. Return 11.68%
This Fund
S&P 500
This Quarter Est. Return
+4.15%
1 Year Est. Return
+11.68%
3 Year Est. Return
+44.44%
5 Year Est. Return
+55.04%
10 Year Est. Return
+251.5%
AUM
$963M
AUM Growth
+$37.8M
Cap. Flow
+$3.99M
Cap. Flow %
0.41%
Top 10 Hldgs %
22.81%
Holding
263
New
13
Increased
78
Reduced
90
Closed
5

Top Buys

Rank Stock Value
1
SSNC icon
SS&C Technologies
SSNC
+$2.27M
2
ADBE icon
Adobe
ADBE
+$1.69M
3
JPM icon
JPMorgan Chase
JPM
+$1.48M
4
ALC icon
Alcon
ALC
+$1.35M
5
BDX icon
Becton Dickinson
BDX
+$873K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$3.28M
2
AL
Air Lease Corp
AL
+$2M
3
DD icon
DuPont de Nemours
DD
+$616K
4
AFL icon
Aflac
AFL
+$611K
5
XOM icon
ExxonMobil
XOM
+$439K

Sector Composition

Rank Sector Weight
1 Technology 17.22%
2 Healthcare 16.87%
3 Industrials 10.43%
4 Consumer Staples 8.73%
5 Financials 8.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SSNC icon
51
SS&C Technologies
SSNC
$18.6B
$5.79M 0.6%
100,498
+37,659
+60% +$2.27M
XBI icon
52
State Street SPDR S&P Biotech ETF
XBI
$9.99B
$5.57M 0.58%
63,522
-1,298
-2% -$111K
CVX icon
53
Chevron
CVX
$371B
$5.43M 0.56%
43,655
+4,238
+11% +$512K
ABBV icon
54
AbbVie
ABBV
$435B
$5.37M 0.56%
73,772
-1,191
-2% -$93.6K
BDX icon
55
Becton Dickinson
BDX
$47B
$5.25M 0.55%
21,351
+3,757
+21% +$873K
CSCO icon
56
Cisco
CSCO
$479B
$5.24M 0.54%
95,692
+57
+0.1% +$3.15K
EEM icon
57
iShares MSCI Emerging Markets ETF
EEM
$29.5B
$4.89M 0.51%
113,868
PFE icon
58
Pfizer
PFE
$147B
$4.86M 0.51%
118,354
-59
-0% -$2.34K
PM icon
59
Philip Morris
PM
$294B
$4.41M 0.46%
56,123
-622
-1% -$51.4K
IFF icon
60
International Flavors & Fragrances
IFF
$22.5B
$4.4M 0.46%
30,313
+1,403
+5% +$195K
CLX icon
61
Clorox
CLX
$12.8B
$4.3M 0.45%
28,110
+256
+0.9% +$39.1K
HD icon
62
Home Depot
HD
$352B
$4.27M 0.44%
20,514
-246
-1% -$49.1K
EOG icon
63
EOG Resources
EOG
$71.5B
$4.19M 0.44%
44,996
+1,887
+4% +$175K
SHW icon
64
Sherwin-Williams
SHW
$89.7B
$4.15M 0.43%
27,153
+108
+0.4% +$16.1K
INTC icon
65
Intel
INTC
$510B
$4.11M 0.43%
85,856
-464
-0.5% -$23K
VTI icon
66
Vanguard Morningstar Total Stock Market ETF
VTI
$681B
$4.11M 0.43%
27,379
+3,132
+13% +$461K
KO icon
67
Coca-Cola
KO
$374B
$4.08M 0.42%
80,053
-100
-0.1% -$4.9K
CMCSA icon
68
Comcast
CMCSA
$87.8B
$4.07M 0.42%
96,281
+12,295
+15% +$519K
CRM icon
69
Salesforce
CRM
$158B
$4.04M 0.42%
26,630
+1,759
+7% +$276K
GLNG icon
70
Golar LNG
GLNG
$5.11B
$3.97M 0.41%
214,737
+2,221
+1% +$42.3K
LKQ icon
71
LKQ Corp
LKQ
$6.1B
$3.94M 0.41%
147,896
-8,980
-6% -$251K
DIS icon
72
Walt Disney
DIS
$177B
$3.77M 0.39%
27,025
+1,359
+5% +$180K
NEOG icon
73
Neogen
NEOG
$2.49B
$3.73M 0.39%
120,000
+3,242
+3% +$95.5K
RPM icon
74
RPM International
RPM
$14.9B
$3.63M 0.38%
59,473
NSC icon
75
Norfolk Southern
NSC
$76.8B
$3.61M 0.38%
18,123

Similar funds

Boston Family Office's Q2 2019 Portfolio in Review

As of Q2 2019, Boston Family Office held 263 positions worth $963M, up 4.1% from $925M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Boston Family Office's Q2 2019 filing shows 13 new, 78 increased, 90 reduced and 5 closed positions. Its largest new stake was Alcon: 23,012 shares worth $1.43M. The largest sale was Celgene Corp, an estimated $3.28M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Industrials.

  • Boston Family Office's largest Q2 2019 buy was Alcon: 23,012 shares worth $1.43M.
  • Boston Family Office added most to SS&C Technologies in Q2 2019, an estimated $2.27M increase.
  • Boston Family Office's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $3.28M.
  • Boston Family Office fully exited Air Lease Corp in Q2 2019, selling an estimated $2M.
  • Boston Family Office's ten largest holdings make up 23% of its $963M portfolio in Q2 2019.
  • Boston Family Office opened 13 new positions and closed 5 in Q2 2019.
  • Boston Family Office's portfolio value rose 4.1% quarter-over-quarter to $963M.

Based on Boston Family Office's 13F filing for Q2 2019, filed 30 Jul 2019.